Hypothalamic-pituitary-adrenal axis function and exposure to stress factors and cannabis use in recent-onset psychosis

References

• Appiah-Kusi E, Leyden E, Parmar S, Mondelli V, McGuire P, Bhattacharyya S. 2016. Abnormalities in neuroendocrine stress response in psychosis: The role of endocannabinoids. Psychol Med. 46:27–45.
   PubMed Web of Science ®Google Scholar
• Arranz S, Monferrer N, Jose Algora M, Cabezas A, Sole M, Vilella E, Labad J, Sanchez-Gistau V. 2018. The relationship between the level of exposure to stress factors and cannabis in recent onset psychosis. Schizophr Res. 201:352–359.
   PubMed Web of Science ®Google Scholar
• Bernard K, Frost A, Bennett CB, Lindhiem O. 2017. Maltreatment and diurnal cortisol regulation: a meta-analysis. Psychoneuroendocrinology 78:57–67.
   PubMed Web of Science ®Google Scholar
• Carol EE, Spencer RL, Mittal VA. 2017. The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis. Psychoneuroendocrinology 83:58–64.
   PubMed Web of Science ®Google Scholar
• Egerton A, Howes OD, Houle S, McKenzie K, Valmaggia LR, Bagby MR, Tseng H-H, Bloomfield MAP, Kenk M, Bhattacharyya S. 2017. Elevated striatal dopamine function in immigrants and their children: a risk mechanism for psychosis. Schizophr Bull. 43:293–301.
   PubMed Web of Science ®Google Scholar
• Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. 2010. International consensus study of antipsychotic dosing. Am J Psychiatry. 167:686–693.
   PubMed Web of Science ®Google Scholar
• Hernandez A, Gallardo-Pujol D, Pereda N, Arntz A, Bernstein DP, Gaviria AM, Labad A, Valero J, Gutiérrez-Zotes JA. 2013. Initial validation of the Spanish childhood trauma questionnaire-short form: factor structure, reliability and association with parenting. J Interpers Violence. 28:1498–1518.
   PubMed Web of Science ®Google Scholar
• Holmes TH, Rahe RH. 1967. The social readjustment rating scale. J Psychosom Res. 11:213–218.
   PubMed Web of Science ®Google Scholar
• Labad J, Armario A, Nadal R, Solé M, Gutiérrez-Zotes A, Montalvo I, Moreno-Samaniego L, Martorell L, Sánchez-Gistau V, Vilella E. 2018. Clinical correlates of hypothalamic-pituitary-adrenal axis measures in individuals at risk for psychosis and with first-episode psychosis. Psychiatry Res 265:284–291.
   PubMed Web of Science ®Google Scholar
• Labad J, Gutiérrez-Zotes A, Creus M, Montalvo I, Cabezas Á, Solé M, Ortega L, Algora MJ, Sánchez-Gistau V, Vilella E. 2016. Hypothalamic-pituitary-adrenal axis measures and cognitive abilities in early psychosis: Are there sex differences?. Psychoneuroendocrinology 72:54–62.
   PubMed Web of Science ®Google Scholar
• Labad J, Stojanovic-Pérez A, Montalvo I, Solé M, Cabezas A, Ortega L. 2015. Stress biomarkers as predictors of transition to psychosis in at-risk mental states: Roles for cortisol, prolactin and albumin. J Psychiatr Res. 60C:163–169.
   Web of Science ®Google Scholar
• Mizrahi R. 2016. Social stress and psychosis risk: common neurochemical substrates? Neuropsychopharmacology. 41:666–674.
   PubMed Web of Science ®Google Scholar
• Mizrahi R, Addington J, Rusjan PM, Suridjan I, Ng A, Boileau I, Pruessner JC, Remington G, Houle S, Wilson AA, et al. 2012. Increased stress-induced dopamine release in psychosis. Biol Psychiatry. 71:561–567.
   PubMed Web of Science ®Google Scholar
• Mizrahi R, Kenk M, Suridjan I, Boileau I, George TP, McKenzie K, Wilson AA, Houle S, Rusjan P. 2014. Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use. Neuropsychopharmacology. 39:1479–1489.
   PubMed Web of Science ®Google Scholar
• Mondelli V, Dazzan P, Hepgul N, Di Forti M, Aas M, D'Albenzio A, Di Nicola M, Fisher H, Handley R, Marques TR, et al. 2010. Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophr Res. 116:234–242.
   PubMed Web of Science ®Google Scholar
• Monteleone P, Filippo CD, Fabrazzo M, Milano W, Martiadis V, Corrivetti G, Monteleone AM, Maj M. 2014. Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure. Psychiatry Res. 215:263–267.
   PubMed Web of Science ®Google Scholar
• Norman RMG, Malla AK. 1991. Subjective stress in schizophrenic patients. Soc Psychiatry Psychiatr Epidemiol. 26:212–216.
   PubMed Web of Science ®Google Scholar
• Phassouliotis C, Garner BA, Phillips LJ, Bendall S, Yun Y, Markulev C, Kerr M, McGorry PD. 2013. Enhanced cortisol suppression following administration of low-dose dexamethasone in first-episode psychosis patients. Aust N Z J Psychiatry. 47:363–370.
   PubMed Web of Science ®Google Scholar
• Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. 2003. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28:916–931.
   PubMed Web of Science ®Google Scholar
• Pruessner M, Cullen A, Aas M, Walker E. 2017. The neural diathesis-stress model of schizophrenia revisited: an update on recent findings considering illness stage and neurobiological and methodological complexities. Neurosci Biobehav Rev. 73:191–218.
   PubMed Web of Science ®Google Scholar
• Ranganathan M, Braley G, Pittman B, Cooper T, Perry E, Krystal J, D'Souza DC. 2009. The effects of cannabinoids on serum cortisol and prolactin in humans. Psychopharmacology (Berl). 203:737–744.
   PubMed Web of Science ®Google Scholar
• Rössler W, Riecher-Rössler A, Angst J, Murray R, Gamma A, Eich D, van Os J, Gross VA. 2007. Psychotic experiences in the general population: a twenty-year prospective community study . Schizophr Res. 92:1–14.
   PubMed Web of Science ®Google Scholar
• Thompson KN, Phillips LJ, Komesaroff P, Yuen HP, Wood SJ, Pantelis C, Velakoulis D, Yung AR, McGorry PD. 2007. Stress and HPA-axis functioning in young people at ultra high risk for psychosis. J Psychiatr Res. 41:561–569.
   PubMed Web of Science ®Google Scholar
• Tomas-Roig J, Piscitelli F, Gil V, Quintana E, Ramió-Torrentà LL, Del Río JA, Moore TP, Agbemenyah H, Salinas G, Pommerenke C, et al. 2018. Effects of repeated long-term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders. CNS Neurosci Ther. 24:528–538.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Hampson AJ, Baler RD. 2017. Don't worry, be happy: endocannabinoids and cannabis at the intersection of stress and reward. Annu Rev Pharmacol Toxicol. 57:285–308.
   PubMed Web of Science ®Google Scholar
• Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D, Sartorius N. 1990. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry. 47:589–593.
   PubMed Web of Science ®Google Scholar